Multi-signal night capture
Phone recording, snoring evidence, disturbed-breathing signals, movement and wakefulness can be reviewed together instead of scattered across separate apps.
NoctaCore investor overview
Building the sleep intelligence layer for report-ready nights.
NoctaCore owns SomnoRoute. The company domain is noctacore.co.uk and the product domain is somnoroute.com. SomnoRoute brings phone recording, snore clusters, disturbed-breathing signals, movement, wakefulness, questionnaires, wearable context and professional PDF reports into one clear night record.
Investment Thesis
Sleep is moving from single-device scores to multi-signal, explainable reports.
- First product: SomnoRoute
- Category: consumer sleep intelligence
- Signals: audio, movement, health context, questionnaires
- Output: professional sleep report PDFs
- Position: awareness and evidence review, not diagnosis
Company
NoctaCore.co.uk
Product
SomnoRoute.com
Market
Sleep health and wearables
Model
Subscription and premium reports
The platform
NoctaCore is not pitching another snore recorder.
SomnoRoute is being built as a multi-signal sleep intelligence product for people who need to understand disrupted nights before, during and after clinical conversations.
Wearable and health context
SomnoRoute can add permission-based Apple Health, Android Health Connect, Watch and Oura Ring context where available, keeping connected data as context rather than diagnosis.
Professional report workflow
Server-calculated overnight and multi-night PDFs turn raw signals into structured evidence that users can understand, save and discuss.
Insomnia-style pattern review
Movement, restlessness, wakefulness, morning notes and questionnaires extend the product beyond snoring into broader sleep disruption.
Why now
Sleep data is abundant. Usable sleep evidence is still scarce.
Consumers have phones, watches, rings and health records, but the data is often fragmented and hard to explain. NoctaCore's opportunity is to make night evidence understandable, exportable and commercially useful while staying careful about medical-device boundaries.
Snoring, wakefulness, fatigue and partner concern are everyday triggers that can bring users into the product.
The same report workflow can expand from snoring into breathing-pattern review, movement, insomnia-style disruption and connected health context.
Multi-night reports, questionnaires, evidence clips and coverage tracking can become a proprietary sleep-pattern dataset with proper consent.
Investor readiness
What investors should see next.
These are the proof points NoctaCore should maintain and update before every investor conversation. Do not invent numbers; replace placeholders with verified metrics only.
Pre-launch waitlist signups, report requests, beta interest, investor enquiries and partner conversations. App downloads should only be reported after app-store launch.
Nights recorded, reports generated, repeat use and questionnaire completion.
Paid subscriptions, premium report purchases, pilots and partner interest.
Testimonials, app reviews, clinic conversations and validation roadmap.
The raise
Suggested pre-seed ask: GBP 300k to GBP 750k.
The exact number should be set once runway, current traction and founder dilution are confirmed. The use of funds should be simple and product-led.
Complete report depth
Ship richer overnight and seven-night reports across snoring, disturbed breathing, movement, insomnia-style patterns and connected health context.
Strengthen wearable routes
Harden Apple Health, Android Health Connect, Watch and Oura Ring flows with consent, coverage checks and clear report language.
Acquire and validate
Fund SEO, AI search, app-store conversion, early user acquisition, pilots and the first validation partnerships.
Safety position
Clear boundaries make the company more investable.
SomnoRoute should remain positioned as a sleep awareness, tracking and report-ready evidence platform unless and until NoctaCore chooses a regulated medical-device path.
Current position
SomnoRoute does not diagnose sleep apnoea, insomnia, breathing disorders or any medical condition. It helps users review patterns and prepare clearer conversations.
Future option
NoctaCore can later pursue validation studies, clinical partnerships or regulated pathways if the commercial case supports it.
Investor contact
Request the NoctaCore investor pack.
For deck, memo, product walkthrough, report samples or founder discussion, contact NoctaCore through the SomnoRoute investor enquiry route.